Possible agent for COVID-19 treatment: Rifampicin.

World J Virol

Department of Pharmacology, Gazi University, Ankara 06500, Turkey.

Published: September 2022

Rifampicin is a promising drug for the treatment of coronavirus disease 2019 based on its antiviral properties and recent studies. studies can serve as a foundation for further studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523331PMC
http://dx.doi.org/10.5501/wjv.v11.i5.391DOI Listing

Publication Analysis

Top Keywords

agent covid-19
4
covid-19 treatment
4
treatment rifampicin
4
rifampicin rifampicin
4
rifampicin promising
4
promising drug
4
drug treatment
4
treatment coronavirus
4
coronavirus disease
4
disease 2019
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!